Article Content
Abstract
Background
In recent years, with the increasing challenges in living conditions, there has been a rise in individuals seeking psychiatric support. This situation may lead to changes in attitudes and perceptions towards psychiatric medication treatments.
Aim
This study aims to examine the attitudes of stable psychiatric patients, healthcare professionals, and the general population toward psychiatric medication treatments.
Method
The study included 311 stable psychiatric patients, 200 healthcare professionals, and 274 participants from the general population. Participants were administered a data form that questioned sociodemographic and clinical characteristics, the Drug Attitude Inventory-10, and the Beliefs about Medicines Questionnaire.
Results
The study reveals significant differences in attitudes towards medication among stable psychiatric patients, non-psychiatric healthcare professionals, and the general population. Stable psychiatric patients tend to have a stronger belief in the positive effects of medication and are more likely to internalize medications in their daily lives. However, this group experiences side effects more intensely compared to other groups. Healthcare professionals maintain a balanced stance regarding the benefits and side effects of medications, while the general population exhibits a more negative attitude towards medications and expresses greater concern about the addictive potential of these drugs.
Conclusion
Considering these differences may contribute to more effective management of treatment processes and improve attitudes toward medications.
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.
- Attitudes
- Behavioral Medicine
- Positive Psychology
- Psychiatric Disorder
- Psychopharmacology
- Psychiatry
Data availability
No datasets were generated or analysed during the current study.
References
-
De Las Cuevas C, Sanz EJ (2007) Attitudes toward psychiatric drug treatment: the experience of being treated. Eur J Clin Pharmacol 63(11):1063–1067. https://doi.org/10.1007/s00228-007-0358-5
-
Triandis HC (1971) Attitude and attitude change, vol 8. Wiley, New York
-
Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig SC, Weissbecker H, Kepplinger HM, Sobota K (1997) Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis 185(3):151–158. https://doi.org/10.1097/00005053-199703000-00004
-
Cooper LA, Brown C, Vu HT, Palenchar DR, Gonzales JJ, Ford DE, Powe NR (2000) Primary care patients’ opinions regarding the importance of various aspects of care for depression. Gen Hosp Psychiatry 22(3):163–173. https://doi.org/10.1016/s0163-8343(00)00073-6
-
Givens JL, Datto CJ, Ruckdeschel K, Knott K, Zubritsky C, Oslin DW, Nyshadham S, Vanguri P, Barg FK (2006) Older patients’ aversion to antidepressants. A qualitative study. J Gen Int Med 21(2):146–151. https://doi.org/10.1111/j.1525-1497.2005.00296.x
-
Angermeyer MC, Däumer R, Matschinger H (1993) Benefits and risks of psychotropic medication in the eyes of the general public: results of a survey in the Federal Republic of Germany. Pharmacopsychiatry 26(4):114–120. https://doi.org/10.1055/s-2007-1014354
-
McLeod JD, Pescosolido BA, Takeuchi DT, White TF (2004) Public attitudes toward the use of psychiatric medications for children. J Health Soc Behav 45(1):53–67. https://doi.org/10.1177/002214650404500104
-
De Las Cuevas C, Peñate W (2015) Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence. Hum Psychopharmacol 30(5):377–383. https://doi.org/10.1002/hup.2487
-
Sajatovic M, Rosch DS, Sivec HJ, Sultana D, Smith DA, Alamir S, Buckley P, Bingham CR (2002) Insight into illness and attitudes toward medications among inpatients with schizophrenia. Psych Serv 53(10):1319–1321. https://doi.org/10.1176/appi.ps.53.10.1319
-
Hoencamp E, Stevens A, Haffmans J (2002) Patients’ attitudes toward antidepressants. Psych Serv 53(9):1180–1181. https://doi.org/10.1176/appi.ps.53.9.1180-a
-
Pogany L, Lazary J (2021) Health control beliefs and attitude toward treatment in psychiatric and non-psychiatric clinical samples. Front Psych 12:537309. https://doi.org/10.3389/fpsyt.2021.537309
-
Lim M, Li Z, Xie H, Tan BL, Lee J (2021) The effect of therapeutic alliance on attitudes toward psychiatric medications in schizophrenia. J Clin Psychopharmacol 41(5):551–560. https://doi.org/10.1097/JCP.0000000000001449
-
Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13(1):177–183. https://doi.org/10.1017/s0033291700050182
-
Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22(2):347–352. https://doi.org/10.1017/s0033291700030282
-
Aydin E, Aydin E, Balaban ÖD, Yumrukçal H, Erkiran M (2018) The validity and reliability of the turkish version of drug attitude inventory-10. Noro psikiyatri arsivi 55(3):238–242. https://doi.org/10.5152/npa.2017.18078
-
Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14(1):1–24
-
Çınar M, Tekgöz E, Çınar Fİ, Yılmaz S (2018) Reliability and validity of the Turkish translation of the Beliefs about Medicines Questionnaire (BMQ-T) in patients with Behçet’s disease. Turkish Thoracic J 19(4):231. https://doi.org/10.5152/TurkThoracJ.2018.180108
-
Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J (2015) Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 25(8):1158–1166. https://doi.org/10.1016/j.euroneuro.2015.04.003
-
Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A (2015) Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PloS one 10(3):e0120560. https://doi.org/10.1371/journal.pone.0120560
-
Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL (2006) Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32(4):724–742. https://doi.org/10.1093/schbul/sbj075
-
Grover S, Chakrabarti S, Sharma A, Tyagi S (2014) Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers. J Neurosci Rural Pract 5(4):374–383. https://doi.org/10.4103/0976-3147.139989
-
Grover S, Mehra A, Chakrabarti S, Avasthi A (2019) Attitude toward psychotropic medications: a comparison of the elderly and adult patients with affective and psychotic disorders. J Geriatric Mental Health 6(2):38–45
-
Vrbová K, Kamarádová D, Látalová K, Ocisková M, Praško J, Mainerová B, Cinculová A, Kubínek R, Ticháčková A (2014) Self-stigma and adherence to medication in patients with psychotic disorders–cross-sectional study. Neuro Endocrinol Lett 35(7):645–652
-
Saleem F, Hassali MA, Shafie AA, Awad AG, Bashir S (2011) Association between knowledge and drug adherence in patients with hypertension in Quetta. Pakistan. Trop J Pharm Res 10(2):125–132. https://doi.org/10.4314/tjpr.v10i2.66552
-
Nebhinani N, Pareek V, Choudhary S, Tripathi S, Singh P, Kumar M (2022) Pathways of care and attitudes toward psychotropics in patients with depressive disorders and psychotic disorders. J Neurosci Rural Pract 13(4):785–790. https://doi.org/10.25259/JNRP-2021-11-39
-
Chakrabarti S (2019) Treatment attitudes and adherence among patients with bipolar disorder: a systematic review of quantitative and qualitative studies. Harv Rev Psychiatry 27(5):290–302. https://doi.org/10.1097/HRP.0000000000000228
-
Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP (2017) Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence 11:449–468. https://doi.org/10.2147/PPA.S124658
Acknowledgements
We are very grateful to all participants of our study for so generously taking the time to take part in our research.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Ethics declarations
Conflicting interests
None.
Declaration of generative AI in scientific writing
During the preparation of this work the author(s) used ChatGPT 4-o in order to improve readability and language. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Reprints and permissions
About this article
Cite this article
Yavuz, S., Yılmaz, Y. & Bahadır, E. Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives. Eur J Clin Pharmacol (2025). https://doi.org/10.1007/s00228-025-03879-7
- Received
- Accepted
- Published
- DOIhttps://doi.org/10.1007/s00228-025-03879-7
Keywords
- Attitudes
- Psychiatric medications
- Outpatients
- Healthcare professionals
- General population